Antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from a Phase 2 clinical trial of ridinilazole (SMT19969) and vancomycin. by Levy CIMAR | Aug 1, 2018 | Publications
Enhanced preservation of the human intestinal microbiota by ridinilazole, a novel Clostridium difficile-targeting antibacterial, compared to vancomycin. by Levy CIMAR | Aug 1, 2018 | Publications
Stereospecific Synthesis of the Saccharosamine-Rhamnose-Fucose Fragment Present in Saccharomicin B by Levy CIMAR | Jul 17, 2018 | Publications
Accelerating Early Antituberculosis Drug Discovery by Creating Mycobacterial Indicator Strains That Predict Mode of Action by Levy CIMAR | Jul 1, 2018 | Publications
Therapeutic Efficacy of Bumped Kinase Inhibitor 1369 in a Pig Model of Acute Diarrhea Caused by Cryptosporidium hominis by Levy CIMAR | Jun 26, 2018 | Publications
